Micronase
Micronase is a diabetes medication containing Glibenclamide, available as 2.5/5mg tablets.
- Category
- Diabetes
- Active ingredient
- Glibenclamide
- Route
- Oral use
- Form
- Tablet
- Strengths
- 2.5/5mg
Prescription rules on Micronase vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Daonil
- Therapeutic Class
- Sulfonylurea
- Pharmacological Class
- Sulfonylurea
- Minor Side Effects
- nausea, weight gain
- Moderate Side Effects
- dizziness, skin rash
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- Sanofi
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage Instructions
- Store at room temperature.
- Drug Interactions
- alcohol, beta blockers